IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $260,000 | -32.5% | 7,899 | -43.7% | 0.18% | -34.4% |
| Q2 2020 | $385,000 | -67.3% | 14,032 | -64.3% | 0.28% | -73.2% |
| Q1 2020 | $1,177,000 | +75.1% | 39,322 | +61.9% | 1.04% | +75.3% |
| Q4 2019 | $672,000 | +74.1% | 24,294 | +14.5% | 0.59% | +56.3% |
| Q3 2019 | $386,000 | -31.3% | 21,213 | -7.4% | 0.38% | -25.6% |
| Q2 2019 | $562,000 | +13.8% | 22,903 | -55.9% | 0.51% | -1.5% |
| Q1 2019 | $494,000 | -3.3% | 51,959 | -10.0% | 0.52% | -3.9% |
| Q4 2018 | $511,000 | – | 57,724 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |